HSPA5 and nonpapillary renal cell carcinoma: Mechanistically, miR‐30a‐5p inhibits tumour growth and cellular proliferation of ccRCC through targeting glucose‐regulated protein78 (GRP78) and modulating unfolded protein response (UPR) pathway.23